Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board

James E. Udelson MD Advisory Board

Peter Libby MD Advisory Board

See All Experts

featured

Published in Cardiology and

Expert Opinion / Interview · June 18, 2018

Cholesterol, Inflammation and Immunotherapy: Current Implications and Future Directions

Written by

Peter Libby MD

Interview by

Jennifer N. Caudle DO

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

Disclosures

Disclosure statements are available on the authors' profiles:

Peter Libby MD

featured

TAVI and FFR-Guided PCI vs Conventional Surgical Aortic Valve Replacement and CABG for Patients With Aortic Valve Stenosis and Complex or Multivessel Coronary Disease

Lancet · December 18, 2024
featured

Using Electrocardiography to Assess Diastolic Function and Prognosis in Mitral Regurgitation

J Am Coll Cardiol · December 18, 2024
featured

Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for Initial Treatment of Hypertension

J Am Coll Cardiol · December 17, 2024
featured

Twofold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis

J Am Coll Cardiol · December 17, 2024
featured

Machine Learning–Based Prediction of Death and Hospitalization in Patients With ICDs

J Am Coll Cardiol · December 16, 2024
featured

Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science

Circulation · December 12, 2024
featured

Bleeding Risk Associated With Concomitant NSAID and Anticoagulant Use After Venous Thromboembolism

Eur Heart J · December 12, 2024
story of the week

Orthostatic and Standing Hypertension and Risk of Cardiovascular Disease

Hypertension · December 11, 2024
featured

Adolescent BP and the Risk of Early Age Stroke

NEJM Evid · December 11, 2024

updated
featured

Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results

Circulation · December 11, 2024
story of the week

Independence of Lipoprotein(a) and LDL Cholesterol-Mediated Cardiovascular Risk

Circulation · December 10, 2024

updated

Obesity, Metabolic Syndrome, and Prediabetes

Cholesterol, Inflammation and Immunotherapy: Current Implications and Future Directions

Additional Info

Further Reading

TAVI and FFR-Guided PCI vs Conventional Surgical Aortic Valve Replacement and CABG for Patients With Aortic Valve Stenosis and Complex or Multivessel Coronary Disease

Using Electrocardiography to Assess Diastolic Function and Prognosis in Mitral Regurgitation

Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for Initial Treatment of Hypertension

Twofold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis

Machine Learning–Based Prediction of Death and Hospitalization in Patients With ICDs

Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science

Bleeding Risk Associated With Concomitant NSAID and Anticoagulant Use After Venous Thromboembolism

Orthostatic and Standing Hypertension and Risk of Cardiovascular Disease

Adolescent BP and the Risk of Early Age Stroke

Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results

Independence of Lipoprotein(a) and LDL Cholesterol-Mediated Cardiovascular Risk

Related Videos